The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
The Antibacterial Peptide Pyrrhocoricin Inhibits the ATPase Actions of DnaK and Prevents Chaperone-Assisted Protein Folding
Abstract
Recently, we documented that the short, proline-rich antibacterial peptides pyrrhocoricin, drosocin, and apidaecin interact with the bacterial heat shock protein DnaK, and peptide binding to DnaK can be correlated with antimicrobial activity. In the current report we studied the mechanism of action of these peptides and their binding sites to Escherichia coli DnaK. Biologically active pyrrhocoricin made of L-amino acids diminished the ATPase activity of recombinant DnaK. The inactive D-pyrrhocoricin analogue and the membrane-active antibacterial peptide cecropin A or magainin 2 failed to inhibit the DnaK-mediated phosphate release from adenosine 5'-triphosphate (ATP). The effect of pyrrhocoricin on DnaK's other significant biological function, the refolding of misfolded proteins, was studied by assaying the alkaline phosphatase and beta-galactosidase activity of live bacteria. Remarkably, both enzyme activities were reduced upon incubation with L-pyrrhocoricin or drosocin. D-Pyrrhocoricin, magainin 2, or buforin II, an antimicrobial peptide involved in binding to bacterial nucleic acids, had only negligible effect. According to fluorescence polarization and dot blot analysis of synthetic DnaK fragments and labeled pyrrhocoricin analogues, pyrrhocoricin bound with a K(d) of 50.8 microM to the hinge region around the C-terminal helices D and E, at the vicinity of amino acids 583 and 615. Pyrrhocoricin binding was not observed to the homologous DnaK fragment of Staphylococcus aureus, a pyrrhocoricin nonresponsive strain. In line with the lack of ATPase inhibition, drosocin binding appears to be slightly shifted toward the D helix. Our data suggest that drosocin and pyrrhocoricin binding prevents the frequent opening and closing of the multihelical lid over the peptide-binding pocket of DnaK, permanently closes the cavity, and inhibits chaperone-assisted protein folding. The biochemical results were strongly supported by molecular modeling of DnaK-pyrrhocoricin interactions. Due to the prominent sequence variations of procaryotic and eucaryotic DnaK molecules in the multihelical lid region, our findings pave the road for the design of strain-specific antibacterial peptides and peptidomimetics. Far-fetched applications of the species-specific inhibition of chaperone-assisted protein folding include the control of not only bacteria but also fungi, parasites, insects, and perhaps rodents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
Freeman, B. C., Myers, M. P., Schumacher, R., & Morimoto, R. I. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07222.x · Cited by 428
A revised mechanism for the alkaline phosphatase reaction involving three metal ions
Stec, B., Holtz, K. M., & Kantrowitz, E. R. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3799 · Cited by 305
Liberek, K., Skowyra, D., Zylicz, M., Johnson, C., & Georgopoulos, C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98713-2 · Cited by 245
Castle, M., Nazarian, A., Yi, S. S., & Tempst, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32555 · Cited by 141
Bulet, P., Ürge, L., Ohresser, S., Hétru, C., & Ötvös, L. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0064q.x · Cited by 128
Aspartate‐Bond Isomerization Affects the Major Conformations of Synthetic Peptides
Szendrei, G. I., Fabian, H., Mantsch, H. H., Lovas, S., NYÉKI, O., Schön, I., & Ötvös, L. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.t01-1-00917.x · Cited by 54
Self-citationHoffmann, R., Dawson, N. F., Wade, J. D., & Ötvös, L. (1997) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1997.tb01178.x · Cited by 17
Self-citation
Cited by
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Huan, Y., Kong, Q., Mou, H., & Yi, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.582779 · Cited by 1,595
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Anti-microbial peptides: from invertebrates to vertebrates
Bulet, P., Stöcklin, R., & Menin, L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0124.x · Cited by 1,107
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Cationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Control of cell selectivity of antimicrobial peptides
Matsuzaki, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.013 · Cited by 713
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Sato, H., & Feix, J. B. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.021 · Cited by 522
Insect Antimicrobial Peptides, a Mini Review
Wu, Q., Patočka, J., & Kuča, K. (2018) · Toxins · doi:10.3390/toxins10110461 · Cited by 481
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target
Evans, C. G., Chang, L., & Gestwicki, J. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100054f · Cited by 436
Antimicrobial Peptides in Drosophila: Structures,Activities and Gene Regulation
Imler, J.-L., & Bulet, P. (2005) · Chemical Immunology and Allergy · doi:10.1159/000086648 · Cited by 423
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
The human beta-defensin-3, an antibacterial peptide with multiple biological functions
Dhople, V., Krukemeyer, A., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.007 · Cited by 355
Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.605-614.2002 · Cited by 354
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
Action of Antimicrobial Peptides against Bacterial Biofilms
Yasir, M., Willcox, M. D. P., & Dutta, D. (2018) · Materials · doi:10.3390/ma11122468 · Cited by 319
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
The Vast Structural Diversity of Antimicrobial Peptides
Koehbach, J., & Craik, D. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.012 · Cited by 294
Antimicrobial Peptides: Versatile Biological Properties
Pushpanathan, M., Gunasekaran, P., & Rajendhran, J. (2013) · International Journal of Peptides · doi:10.1155/2013/675391 · Cited by 292
Host defence peptides from invertebrates – emerging antimicrobial strategies
Hancock, R. E. W., Brown, K. L., & Mookherjee, N. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.10.017 · Cited by 282
Structural determinants of antimicrobial activity in polymers which mimic host defense peptides
Palermo, E. F., & Kuroda, K. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2687-z · Cited by 281
Advances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Antimicrobial peptides: structure, functions and translational applications
Oliveira Júnior, N. G., Souza, C. M., Buccini, D. F., Cardoso, M. H., & Franco, O. L. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01200-y · Cited by 276
Antibiofilm activity of host defence peptides: complexity provides opportunities
Hancock, R. E. W., Alford, M. A., & Haney, E. F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00585-w · Cited by 270
Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action
Scocchi, M., Tossi, A., & Gennaro, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0721-7 · Cited by 267
Antimicrobial peptides with cell-penetrating peptide properties and vice versa
Splith, K., & Neundorf, I. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0682-7 · Cited by 265
Hanson, M. A., Dostálová, A., Ceroni, C., Poidevin, M., Kondo, S., & Lemaitre, B. (2019) · eLife · doi:10.7554/elife.44341 · Cited by 261
Antimicrobial peptides: promising compounds against pathogenic microorganisms
Cruz, J., Ortiz, C., Guzmán, F., Fernández-Lafuente, R., & Torres, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217110155 · Cited by 166
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Zahn, M., Berthold, N., Kieslich, B., Knappe, D., Hoffmann, R., & Sträter, N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.041 · Cited by 126
Self-citationHanson, M. A., Kondo, S., & Lemaitre, B. (2022) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2022.0773 · Cited by 31
Metadata
- Authors
- Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-02-10
- Volume
- 40
- Issue
- 10
- Pages
- 3016-3026
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2054607729
- Cited by
- 491
- References
- 8
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.